| Financial Year |
March 31 2023 |
| Monetary Funds |
640,584,567.58 |
| Held-for-trading Financial Assets |
235,842,236.61 |
| Notes Receivable |
-- |
| Accounts Receivable |
301,828,386.70 |
| Advances to Suppliers |
34,131,789.21 |
| Other Receivables |
16,468,396.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
583,223,020.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,548,107.74 |
| Total Current Assets |
1,926,536,314.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,964,965.91 |
| Investment Properties |
-- |
| Fixed Assetes |
263,394,824.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
102,409,640.62 |
| R&D expenses |
-- |
| Goodwill |
641,471,876.44 |
| Long-Term Deferred and Prepaid Expenses |
7,244,935.82 |
| Deferred Income Tax Assets |
42,484,441.18 |
| Other Non-Current Assets |
28,939,157.68 |
| Sub-Total of Non-Current Assets |
1,193,134,699.52 |
| Total Assets |
3,119,671,013.72 |
| Short-Term Loans |
71,504,201.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,345,074.24 |
| Accounts Payable |
383,037,482.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,075,270.09 |
| Taxes Payable |
65,082,299.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
77,086,611.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,079,879.64 |
| Other Current Liabilities |
15,008.94 |
| Sub-Total of Current Liabilities |
670,201,536.52 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
45,228,985.20 |
| Deferred Income Tax Liabilities |
12,313,923.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
164,484,970.14 |
| Total Liabilities |
834,686,506.66 |
| Paid-In Capital(Or Share Stock) |
289,175,621.00 |
| Capital Surplus |
1,701,461,918.49 |
| Surplus Reserve |
5,368,192.82 |
| LESS:Treasury Stock |
236,231,675.09 |
| Undistributed Profits |
346,096,166.91 |
| Minority Stockholder's Interest |
143,164,618.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,141,819,888.40 |
| Owner's Equity（Stockholder's Equity） |
2,284,984,507.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,119,671,013.72 |
